சைபீரியா அடிப்படையிலானது திசையன் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சைபீரியா அடிப்படையிலானது திசையன் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சைபீரியா அடிப்படையிலானது திசையன் நிறுவனம் Today - Breaking & Trending Today

Russia's 3rd vaccine: CoviVac developer tells RT new jab uses classic 'dead virus' technology — RT Russia & Former Soviet Union

Follow RT on
The third Covid-19 vaccine registered in Russia is based on a “perfectly conventional” platform, and those who have been injected experienced no side effects, the head of the Chumakov Scientific Center, which created it, told RT.
The CoviVac vaccine received national approval in Russia on February 20. The first batch of doses is expected to be available to the public in mid-March, according to the government.
The vaccine is based on the most traditional technology that has been around for a long time and is widely used throughout the world, Aidar Ishmukhametov, the director general of the Chumakov Scientific Center, told RT. ....

South Africa , Stavropol Skiy Kray , United Kingdom , South African , Aidar Ishmukhametov , Chumakov Center , Research Of The World Health Organization , Centre For Poliovirus , Chumakov Scientific Center , Russian Direct Investment Fund , Vector Institute , Collaborating Centre , Enterovirus Surveillance , World Health Organization , Siberia Based Vector Institute , ஒன்றுபட்டது கிஂக்டம் , ஆராய்ச்சி ஆஃப் தி உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ரஷ்ய நேரடி முதலீடு நிதி , திசையன் நிறுவனம் , ஒத்துழைத்தல் மையம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சைபீரியா அடிப்படையிலானது திசையன் நிறுவனம் ,

Russian-made Sputnik V and EpiVacCorona vaccines are effective against UK variant of coronavirus – watchdog

Follow RT on
Russia’s Sputnik V and EpiVacCorona vaccines have been proven to be effective against the UK variant of the coronavirus, a government agency has said.
Serum obtained from people who took the Sputnik V and EpiVacCorona vaccines and had antibodies to the novel coronavirus, demonstrated a
“protective effect” against the UK variant, Russia’s consumer protection agency, Rospotrebnadzor, said in a statement to the media.
It added that the vaccines have shown to be just as good against the British strain as they are against the ordinary SARS-CoV-2 virus, which causes Covid-19.
The research was carried out by the Siberia-based Vector Institute, which developed EpiVacCorona. Russian President Vladimir Putin previously asked it to check whether the country’s vaccines are effective against the new strains of the virus. EpiVacCorona was cleared for mass production back in December, with the first batch of 45,000 doses released for sale t ....

United Kingdom , Vladimir Putin , Gamaleya Institute , Vector Institute , Siberia Based Vector Institute , Russian President Vladimir Putin , Moscow Based Gamaleya Institute , Advanced Western , ஒன்றுபட்டது கிஂக்டம் , விளாடிமிர் புட்டின் , திசையன் நிறுவனம் , சைபீரியா அடிப்படையிலானது திசையன் நிறுவனம் , ரஷ்ய ப்ரெஸிடெஂட் விளாடிமிர் புட்டின் ,